Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 2011

View Archived Issues

New phase I/II data on vector-based malaria vaccines

Preclinical data support advancement of new Servier product to clinic

Intellikine divulges preclinical data on INK-1117

New phosphodiesterase 10A inhibitors claimed

Novel serine/threonine-protein kinase ATR inhibitors prepared by Vertex

Belgian authorities clear phase I/II combination treatment study in metastatic melanoma

FDA grants standard review status for carfilzomib NDA

First data reported on Graspa in older patients with Ph- ALL

CSF-1-R-targeted antibody shows promise in proof-of-principle study

Pharmaxis reaches recruitment target in Bronchitol trial

Arcarios receives loan to develop osteoarthritis drug candidate

Chinese organizations patent new anticancer agents

Anacor Pharmaceuticals reports phase IIa data on AN-2728 and AN-2898

Novel pancreatic cancer vaccine enters clinic

Ablynx and Merck Serono select Nanobody for preclinical development

Celladon heart failure therapy receives FDA fast track status

Genentech begins first-in-human study of IL-17-directed antibody

Geron begins phase II study of GRN-1005

New inhibitors of cytokine signaling designed in U.S.

Eisai reports new agents with antitumor potential

MicroRNA therapeutics discovery effort begins in glioblastoma multiforme

Novel histamine H3 receptor antagonists/inverse agonists reported

Repros Therapeutics reports topline data on Androxal in hypogonadism and type 2 diabetes

Cubist Pharmaceuticals acquires Adolor

Transition Therapeutics begins phase I TT-401 trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...